History of Chugai Pharmaceutical

Understanding Chugai’s history that fostered the business philosophy “Innovation all for the patients”

Chugai merged with Nippon Roche in 2002 based on a strategic alliance agreement with Roche.

  • History of Chugai Pharmaceutical
  • History of Nippon Roche
1980
1980
Nippon Roche

J.C. Froidevaux appointed as Representative Director and President

1981
Chugai

Launched Alfarol®, an active vitamin D3 derivative (Jan.)

Chugai

Started research and development of treatment for rheumatoid arthritis

1981
Nippon Roche

Launched Madopar®, an anti-Parkinsonism agent (Feb.)

1982
Chugai

Opened New York office (Oct.)

1983
Chugai

Purchased equity of a US venture, Genetics Institute Inc. (Oct.)

1986
The team of Dr. Tadamitsu Kishimoto from Osaka University reported “interleukin 6(IL-6)”
1986
Chugai

Start of the collaborative research on IL-6 inhibitors (now Actemra®) with Osaka University

Chugai

Opened London office (Mar.)

1986
Nippon Roche

Launched Rocephin®, a cephem antibiotic agent (Aug.)

1987
Chugai

Hajime Sano appointed as Representative Director and President (Mar.)

Chugai

Constructed the Fuji-Gotemba Research Laboratory (Shizuoka Prefecture) (Jun.)

1988
Nippon Roche

Established Diagnostics Headquarters (Mar.)

1989
Chugai

Acquired Gen-Probe Incorporated (United States) (Dec.)

1989
Nippon Roche

R.A. Meyer appointed as Representative Director and President

1990
Chugai

Constructed the Utsunomiya Plant (Tochigi Prefecture) (Oct.)

1992
Chugai

Established C&C Research Laboratories in Korea (Jan.)

Chugai

Osamu Nagayama appointed as Representative Director and President (Sep.)

1993
Chugai

Chugai announced “the vision of 21st century”

1993
Nippon Roche

Hiroaki Shigeta appointed as Representative Director and President

1994
Chugai

Converted the London office (opened March 1986) into Chugai Pharma Europe Ltd., an overseas subsidiary (United Kingdom) (Jan.)

1997
Chugai

Established Chugai Diagnostics Science Co., Ltd. (Tokyo) (Mar.)

Chugai

Established Chugai Pharma Marketing Ltd. (United Kingdom, now Chugai Pharma Europe Ltd.) (Dec.)

1998
Nippon Roche

Established Roche Vitamin Japan K.K. (Feb.)

Nippon Roche

Spun-off the Diagnostics Headquarters as Roche Diagnostics K.K. (Aug.)

1999
Nippon Roche

Launched CellCept® an immunosuppressant agent (Nov.)

1999

Learn more about the turning points of this age

  1. The challenge of biotech became today’s cornerstone (1980 - 1990s)
  • Like
  • Tweet
  • LINE it!
  • E-mail

History of Chugai Pharmaceutical

Back to top